157 related articles for article (PubMed ID: 1478605)
1. [Therapy with H2 receptor antagonists in childhood. Use of ranitidine in duodenal and gastric ulcer and reflux esophagitis].
Bender SW
Fortschr Med; 1992 Nov; 110(33):629-32. PubMed ID: 1478605
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
3. Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and reflux esophagitis: a multicentre study.
Anand BS; Balakrishnan V; Desai D; Habibullah CM; Joshi VG; Kalro RH; Misra RC; Nigam DK; Parikh KN; Puri DS
Indian J Gastroenterol; 1986 Oct; 5 Suppl():29-33. PubMed ID: 3539782
[No Abstract] [Full Text] [Related]
4. Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.
Frampton JE; McTavish D
Pharmacoeconomics; 1994 Jul; 6(1):57-89. PubMed ID: 10147354
[TBL] [Abstract][Full Text] [Related]
5. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
Forssell H; Koch G
Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
[TBL] [Abstract][Full Text] [Related]
6. Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and reflux esophagitis: a multicentre study.
Indian J Gastroenterol; 1986 Oct; 5 Suppl():35-44. PubMed ID: 3539783
[No Abstract] [Full Text] [Related]
7. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study.
Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P
Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287
[TBL] [Abstract][Full Text] [Related]
8. Duodenal and gastric ulcer healing rates: a review.
Legerton CW
Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
[TBL] [Abstract][Full Text] [Related]
9. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Bardou M
Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
[No Abstract] [Full Text] [Related]
10. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
Bories P; Tournade JM; Alberola B; Pappo M
Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
[TBL] [Abstract][Full Text] [Related]
11. A comparison of 4-week peptic ulcer healing rates following treatment with antacids and ranitidine.
Bezuidenhout DJ; Perold JG; Adams G
S Afr Med J; 1984 Jun; 65(25):1007-9. PubMed ID: 6328685
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
Barradell LB; McTavish D
Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of acid-related diseases of the gastrointestinal tract. Observations in patients receiving a single evening dose of 300 mg ranitidine].
Sewing KF; Franz E
Fortschr Med; 1992 Mar; 110(7):114-6. PubMed ID: 1559647
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial].
Amouretti M; Ansenay M; Bader JP; Baillet J; Bel A; Belaïche J; Benzenou A; Bertrand G; Bonfils S; Boucekkine T
Gastroenterol Clin Biol; 1985 Feb; 9(2):147-52. PubMed ID: 3884426
[TBL] [Abstract][Full Text] [Related]
15. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
Classen M; Dammann HG; Domschke W; Hüttemann W; Londong W; Rehner M; Simon B; Witzel L; Berger J
Hepatogastroenterology; 1985 Oct; 32(5):243-5. PubMed ID: 3908262
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
Young MD; Lottes SR; Webb LA
Clin Ther; 1988; 10(5):543-52. PubMed ID: 2856597
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
19. Review of peptic ulcer maintenance trials.
Robinson M
Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.
Lancaster-Smith MJ; Jaderberg ME; Jackson DA
Gut; 1991 Mar; 32(3):252-5. PubMed ID: 2013419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
